Oral drug Roxadustat safe and effective for anemia treatment in kidney disease patients: Study
Roxadustat was shown to be effective, with an acceptable safety profile. USA: An oral drug called roxadustat is effective for the treatment of anemia in patients with chronic kidney disease, shows pooled results from recent clinical trials. The study results appear in the Clinical Journal of the American Society of Nephrology (CJASN).
Many people with kidney dysfunction develop anemia -- a shortage of healthy red blood cells that carry oxygen to the body's tissues. Some anemia treatments may lead to serious cardiovascular side effects.
To evaluate the efficacy and cardiovascular safety of one such inhibitor -- called roxadustat -- Robert Provenzano, MD (Wayne State University School of Medicine) and his colleagues analyzed data pooled from three phase 3 studies of roxadustat in patients with chronic kidney disease and anemia.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.